Skip to main content
. 2016 Mar 1;77:787–795. doi: 10.1007/s00280-016-2987-9

Fig. 2.

Fig. 2

Plasma concentration–time profile after multiple doses (study day 8) of AZD5363 for a continuous dosing and b intermittent dosing. *360 mg bid 4 on/3 off and 480 mg bid 4 on/3off; 640 mg bid 2 on/5 off